News & Events
Featured
News
- Press ReleaseJune 12, 2026
Goodwin Represents Parabilis Medicines in Strategic Collaboration With Regeneron Pharmaceuticals for Up to $2.3 Billion
- Press ReleaseJune 12, 2026
Goodwin Advises Engitix on Strategic Collaboration With GSK for £44.5 Million Upfront and Up to £118 Million in Milestones
- Press ReleaseJune 12, 2026
Goodwin Advises La Caisse on Investment Supporting TPG’s $2 Billion Acquisition of ECHO Realty
- Press ReleaseJune 12, 2026
Goodwin Guides Parabilis Medicines on Upsized $770.5 Million Initial Public Offering and $75 Million Private Placement to Regeneron Pharmaceuticals
Events
- Speaking EngagementsJune 25, 2026
AI on the Docket: How AI is Transforming the Practice of Antitrust Law
- Speaking EngagementsJune 17, 2026
Federal Circuit Bar Association’s 2026 Bench & Bar Conference
- Speaking EngagementsJune 16, 2026
Getting Ahead of What’s Next: What Today’s Regulation, Disclosure Trends, and AI Mean for Public Companies
- WebinarJune 10, 2026 | 2:00 PM ET
Hikma v. Amarin: What the Supreme Court's Decision Means for Skinny Labeling and Induced Infringement
Media Contact
Email
press@goodwinlaw.com
Phone
United States: +1 617 570 1500
Europe: +44 20 7447 4240
Asia: +852 3658 5305